Tom 15, Nr 4 (2020)
Artykuł przeglądowy
Opublikowany online: 2020-11-24
Wyświetlenia strony
220
Wyświetlenia/pobrania artykułu
355
Nauka w erze pandemii — wirtualne sesje naukowe American College of Cardiology i World Heart Federation, 28–30 marca 2020
1
, 1
, 1
Folia Cardiologica 2020;15(4):330-332.
Streszczenie
The authors present the recent results of new clinical trials, which were released during Scientific Sessions of ACC - Chicago 2020
Słowa kluczowe: badania klinicznerelacja z kongresuleczenie innowacyjne
Referencje
- Armstrong PW, Pieske B, Anstrom KJ, et al. VICTORIA Study Group. Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med. 2020; 382(20): 1883–1893.
- Bonaca MP, Bauersachs RM, Anand SS, et al. Rivaroxaban in peripheral artery disease after revascularization. N Engl J Med. 2020; 382(21): 1994–2004.
- Rechcinski T, Kasprzak J. Nie tylko ISCHEMIA. Sprawozdanie z American Heart Association’s Scientific Sessions 2019, Filadelfia 16–18 listopada 2019 roku. Folia Cardiol. 2020; 15(1): 84–87.
- Reynolds HR, Shaw L, Min J, et al. Coronary anatomy, ischemia and angina: associations at baseline in the ISCHEMIA trial. J Am Coll Cardiol. 2020; 75(11 Suppl 1): 21.
- Reynolds HR, Shaw L, Chaitman B, et al. Sex differences in stress test and CCTA findings and symptoms in the randomized ISCHEMIA trial. J Am Coll Cardiol. 2020; 75(11 Suppl 2): 30.
- Ho CY, Mealiffe M, Bach R, et al. Evaluation of mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2020; 75(21): 2649–2660.
- Rechciński T, Cieślik-Guerra U, Siedlecki P, et al. Flow-mediated skin fluorescence: a novel method for the estimation of sleep apnea risk in healthy persons and cardiac patients. Cardiol J. 2020 [Epub ahead of print].
